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Abstract
Background—Moderately premature infants, defined here as those born between 30 0/7 and 34
6/7 weeks gestation, comprise 3.9% of all births in the United States and 32% of all preterm
births. While long-term outcomes for these infants are better than for less mature infants,
morbidity and mortality are still substantially increased in comparison to infants born at term.
There is an added survival benefit resulting from birth at a tertiary neonatal care center, and
although many of these infants require tertiary level care, delivery at lower level hospitals and
subsequent neonatal transfer are still common.
Objective—Our primary aim was to determine the impact of maternal characteristics and
antenatal medical management on the early neonatal course of the moderately premature infant.
The secondary aim was to create a clinical prediction rule to determine which infants require
intubation and mechanical ventilation in the first 24 hours of life. Such a prediction rule could
inform the decision to transfer maternal-fetal patients prior to delivery to a facility with a Level III
Neonatal Intensive Care Unit (NICU), where optimal care could be provided without the
requirement for a neonatal transfer.
Methods—Data for this analysis came from the cohort of infants in the Moderately Premature
Infant Project (MPIP) database, a multi-center cohort study of 850 infants born at gestational age
30 0/7 to 34 6/7 weeks, who were discharged home alive. We built a logistic regression model to
identify maternal characteristics associated with need for tertiary care, as measured by
administration of surfactant. Using statistically significant covariates from this model, we then
created a numerical decision rule to predict need for tertiary care.
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tResults—In multivariate modeling, 4 factors were associated with reduction in the need for
tertiary care, including, surfactant administration, including non-White race (OR=0.5, [0.3, 0.7],
older gestational age, female gender (OR=0.6 [0.4, 0.8]) and use of antenatal corticosteroids
(OR=0.5, [0.3, 0.8]). The clinical prediction rule to discriminate between infants who received
surfactant, versus those who did not, had an area under the curve of 0.77 [0.73, 0.8].
Conclusions—Four antenatal risk factors are associated with a requirement for Level III NICU
care as defined by the need for surfactant administration. Future analyses will examine a broader
spectrum of antenatal characteristics and revalidate the prediction rule in an independent cohort.
Keywords
infant; newborn; transport; clinical prediction rule; ROC Curve
INTRODUCTION
Beginning in the 1960s, regionalization of perinatal care has contributed substantially to
improve neonatal outcomes, specifically in regards to the most appropriate location of birth
of premature infants 1, 2, 3, 4, 5, 6, 7, 8, 9. As part of this effort, the American Academy of
Pediatrics (AAP) developed guidelines for the optimal place of delivery of neonatal care
based on certain criteria. The AAP defines the hospital levels of newborn care that should be
provided within individual nurseries. These range from Level I nursery, where basic
neonatal care is provided to well infants, to Level III neonatal intensive care units (NICUs),
where a full range of pediatric subspecialty services are available for treatment of premature
and critically ill term neonates10. Level II, or intermediate neonatal care, is intended for
infants greater then or equal to 32 weeks gestation and birthweight of greater then 1,500
grams 10. The current recommendations from the AAP and American Congress of Obstetrics
and Gynecology (ACOG) suggest that women presenting in labor before 32 weeks gestation
are best delivered at a hospital with a Level III NICU, thus requiring antenatal referral/
transfer of the mother 11.
Currently, the aforementioned guidelines are limited by only using the gestational age cut-
off when applied to the care of moderately premature infants, defined here as those between
30 0/7 and 34 6/7 weeks gestation, who comprise 3.9% of all births in the United States
(US) and 32% of all preterm births 12, 13. This group has a relatively low risk of morbidity
and mortality, although substantially increased when compared to infants born at term 12, 14.
Therefore, most of these infants can be managed at a Level II facility; however, Escobar et
al. demonstrated that 25% of these infants received surfactant, while 21.3% of infants <32
6/7 weeks gestation required ventilation for longer than 3 days 12. Thus, a substantial portion
of these infants would require neonatal transfer, with its attendant risks, if born at hospitals
that are not equipped to properly manage that severity of illness.
Many women with threatened preterm delivery between 30 0/7 and 34 6/7 weeks could be
transferred to a Level III facility emergently. However, this strategy has some substantial
drawbacks. The most implicit reason is the immediate risk to the mother, neonate, or both,
should delivery occur in transport. Structural limitations, such as payer or networking
restrictions, may also play a role 15. Perhaps most importantly, moderately premature
infants, without other fetal anomalies, are relatively low risk compared to the very low birth
weight (VLBW) population 12, 16, and thus often can be treated at a Level II facility.
Therefore, clinicians might not feel compelled to transfer the maternal-fetal patient.
The optimal strategy would be to identify infants who are likely to need Level III care
antenatally so that maternal-fetal transfer can take place prior to delivery. Antenatal transfer,
which has been shown to be both safe and beneficial 17, 18, is essential to provide immediate
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toptimal care for the critically ill newborn, avoid transport of a critically ill newborn, and
minimize maternal-infant separation. Unfortunately, we currently do not have the ability to
identify infants who would benefit from this strategy.
In this study, we sought to determine the impact of maternal characteristics and antenatal
medical management on the early neonatal course of the moderately premature infant and to
derive a clinical prediction rule to determine which infants require tertiary neonatal care in
the first 24 hours of life and thus prompt antenatal maternal transfer.
METHODS
Study Design and Patient Population
We undertook a retrospective analysis of infants in the Moderately Premature Infant Project
(MPIP) database. MPIP is a multi-center cohort that contains prospectively collected data in
combination with a retrospective chart review and post-discharge telephone interviews. The
patients were assembled between 2001 and 2003 from a combination of ten Level II and
Level III NICUs in California and Massachusetts. MPIP includes 850 infants born at 30 0/7
to 34 6/7 weeks gestational age, who were discharged home alive from the study hospital.
The cohort has been previously described in more detail 12, 19, 20, 21, 22, 23. The original aims
of MPIP were to describe the epidemiology of this low risk group of moderately premature
infants and to develop a comprehensive length of stay model 12. The data collection had
been previously approved by the institutional review boards of the participating centers and
the Harvard School of Public Health, and there is ongoing approval for secondary analyses
from the Beth Israel Deaconess Medical Center.
Outcome Variable
The primary outcome measure was whether or not the infant received surfactant, which
served as a surrogate for requirement for Level III NICU care. This was chosen as the
primary outcome because most of the infants who are intubated in this age group receive
surfactant, and the need for respiratory support is a key part of the definition of Level III
care 10, 11. Surfactant administration occurred either immediately after birth or after an
infant failed non-invasive measures of respiratory support. Details on prophylactic surfactant
use were not available in this database.
Predictor Variables
Predictor variables were selected if they were maternal factors that could contribute to the
neonate’s health status at birth, as determined either by biologic plausibility, previously
known associations, or potential for an association. A total of 20 potential exposures were
identified from the database. Baseline maternal demographics such as maternal age,
gestational age at delivery, gravidity and parity, maternal race, education and income were
included. In addition, maternal intrapartum characteristics (i.e. antenatal corticosteroids,
intrapartum antibiotics, magnesium sulfate and/or other tocolytics, presence and duration of
rupture of membranes) and pregnancy characteristics (i.e. infertility treatment, multiple
gestation, history of illicit drug use, history of spontaneous and therapeutic abortions) were
evaluated. Finally, in order to account for inter-NICU variability and regional variability, we
included the level of care (i.e. II vs. III) and the state of birth (i.e. California vs.
Massachusetts) as potential predictors. Excluded potential predictors were the mode of
delivery and infant birthweight, since the aim of our analysis was to determine the impact of
only the antenatal variables on the moderately preterm infant, and neither of the
aforementioned factors could be accurately determined prior to delivery. The database did
not have the detail level of maternal medical history, such as pregnancy related diseases,
diabetes, or smoking history.
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20% of the patients (173 out of 850) who were not captured by the follow up survey 3
months after discharge. The survey comparison between survey respondents and non-
respondents has been previously described 20; the infants were of similar gestational age and
birthweight in both groups, but the mothers tended to be slightly older, to have twin or
higher gestation, and were more likely to breastfeed in the respondent group 20. However,
the 20% missing data only applied to 4 of our 20 predictor variables: maternal race, maternal
education, infertility treatment, and family income. Of these four variables, only one,
maternal race, showed a statistically significant association with the dependent variable. For
this variable we assigned the missing group to the non-White category. The results of the
final logistic regression model were similar when those patients were excluded from the
analysis all together. We excluded family income as a predictor variable because an
additional 12.3% of patients declined to answer.
Statistical Analysis
The initial objective was to determine the impact of maternal characteristics and antenatal
medical management on the early neonatal course of the moderately premature infant. A
weighted analysis was used in order to account for the sampling variation at different MPIP
sites 12 (actual N=850 represents a total sample of N=1250). Additionally, clustering for
twins and higher order multiples performed as multiple gestation accounted for 39.1% of the
cohort. Weighted regression and chi-square analyses were used as appropriate to explore the
bivariate relationship between the individual exposure variables and the outcome of interest.
All means and percentages reflected the weighted analyses. Twenty variables were
identified, and those with p-value <0.2 were included in a multivariable logistic regression
model. Approximately 25% of our patients had the outcome of interest. By using a general
rule of 1 predictor per 10 patients with the primary outcome of interest 24, we anticipated
adequate power to allow exploration of the 21 candidate variables.
In order to create a clinical prediction rule, we incorporated the significant factors from the
multivariable model using a weighted point system, in which the value of each variable is
derived from the regression model beta coefficients multiplied by a factor of 10. This
conversion was the same methodology used to derive the SNAP-II 25 and Richardson
Score 26, two clinical scores used to predict neonatal mortality and the need for prolonged
mechanical ventilation, respectively. Receiver Operating Characteristic (ROC) curves were
used to demonstrate the optimal cut-off value for the derived score, the Maternal Antenatal
Transport Score (MATS). The c-statistic was calculated to determine the area under the
curve. As a validation technique for MATS, nonparametric bootstrapping was used to derive
the 95% confidence interval around the score.
Data were analyzed using SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).
RESULTS
The characteristics of the study populations are detailed in Tables 1 and S1. The mean
gestational age of the MPIP cohort was 33 1/7 weeks, with a mean birth weight of 1,933
grams. About two thirds of the cohort was born at a Level III NICU, with an almost even
contribution of births from California and Massachusetts units. Two thirds of the cohort
received antenatal corticosteroids, and more than half were delivered by Cesarean section.
Notably, almost all of the women received prenatal care. Nearly 30% of the pregnancies
were secondary to infertility treatment, and the cohort consistent mainly of White women of
higher education and family income (Tables 1 and S1).
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tAs expected, the group that received surfactant was, on average, less mature (8 days) and
smaller (180 grams) compared to the group that did not receive surfactant. Additional
notable trends or differences in the surfactant group included more frequent receipt of
antenatal corticosteroids and magnesium sulfate, rupture of membranes greater then 24
hours, and birth in the state of California, as well as a higher likelihood of White race and
male gender. There were no differences in maternal age, maternal education or family
income between the two groups (Table S1).
The resulting multivariable logistic regression model is presented in Table 2, demonstrating
only the four statistically significant variables, the odds ratio, and the respective MATS
points generated for each item. Lower gestational age increased the odds of requiring Level
III NICU care, while female gender, non-White race, and antenatal corticosteroids decreased
the odds. Of note, a higher proportion of mothers received antenatal corticosteroids in the
surfactant group (70.8%) as compared to the no-surfactant group (64.9%), with a non-
statistically significant trend (p=0.16). However, the multivariable model, as expected,
demonstrated the use of antenatal corticosteroids to be a protective factor with an odds ratio
of 0.6 [0.4, 0.9] (Table 2). The trend towards higher antenatal corticosteroid use in the
surfactant group is most likely explained by the fact that those infants were of lower
gestational age.
The statistically significant factors from the multivariable model were included in the
MATS. The possible scores range from 0 (i.e. 34 weeks, female gender, received antenatal
corticosteroids, and non-white race) to 48 (i.e. 30 weeks, male gender, no antenatal
corticosteroids, and white race). The mean score for the overall cohort was 16 (SD=10.7),
with a score of 24.9 (SD=10.8) for the surfactant group and 14.2 (SD=9.3) for the no-
surfactant group (p<0.0001) (Table 3). Figure 1 shows the true positive and false positive
rates for various score cut-offs in a Receiver Operating Curve, which has an Area Under the
Curve of 0.77 [0.73, 0.8] (Hosmer and Lemenshow Goodness of Fit Test p-value=0.76).
Table 4 demonstrates the comparison of two MATS cut-off values with the AAP/ACOG
referral/antenatal transfer threshold of less then 32 weeks gestation. The MATS cut off value
represents the mean MATS in the two groups, surfactant (24.9) and no surfactant (14.2). The
application of MATS improves the sensitivity of antenatal identification of infants who
require tertiary care. However the specificity is decreased as compared to the current
gestational age cut off, thus resulting in higher number of maternal transports of infants who
will not require tertiary care (i.e. higher false positives) (Table 4). When the rule is applied
to the MPIP cohort, the gestational age cut off would result in the fewest antenatal
transports, but would miss the largest number of infants requiring tertiary care and thus a
postnatal transport.
DISCUSSION
We have developed a simple score that uses clinical parameters to help predict the
requirement for tertiary level neonatal care in the first 24 hours of life prior to the delivery of
a moderately premature infant. The MATS includes four simple and readily-available
parameters: fetal sex, gestational age, administration of antenatal corticosteroids and
maternal race.
Several clinical prediction scores in the field of neonatology have helped to build the
framework for our antenatal risk assessment score. These include the Score for Neonatal
Acute Physiology (SNAP) 25, 27, Clinical Risk Index for Babies (CRIB) 28, 29, 30,
Richardson Score 26, and the Mortality Index for Neonatal Transportation (MINT) Score 31.
As does MATS, all of these rules incorporate either physiology alone or a combination of
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tphysiologic parameters and readily available neonatal clinical factors that are associated
with severity of illness. In contrast to MATS, however, all focus on postnatal prediction of
clinical events, ranging from mortality to prolonged ventilation. To our knowledge, only one
previous study attempted to identify exclusively intrapartum factors to predict the severity of
illness of the neonate 16, but the analysis was in a different health care delivery setting in
France, only included infants up to 32 weeks gestation and did not derive a clinical
prediction score. In addition, the Alberta Perinatal Health Plan uses an Antepartum Risk
Score for all pregnant women to help identify the high risk pregnancies for that region to
help guide the obstetric providers throughout the pregnancy 32. However, this risk score is
intended to be used throughout the antenatal period to assess maternal risk, and does not
explicitly focus only on the high risk infants 32.
The discriminatory performance of MATS, with a c-statistic of 0.77 [0.73, 0.8], is in the
moderate range and is similar to other recently published models for survival without
disability in extremely premature infants 33, prediction of discharge time in infants under 27
weeks gestation 34, and transport risk assessment for prediction of 7-day and total NICU
mortality 35. In addition, a model matching the current AAP/ACOG11 guidelines (i.e.,
transfer if < 32 weeks) had a c statistic of 0.65. In contrast, the MATS offers a 15%
improvement in the area under the curve, thus leading to improved ability to antenatally
discriminate the need for tertiary neonatal care.
Since this was a secondary data analysis, we must acknowledge certain limitations in our
work. First, not all variables that might signal a need for tertiary care were available in our
prospective cohort (e.g. hypoglycemia requiring central access, hypotension requiring
pharmacologic support, etc). We used a surrogate outcome for the requirement of tertiary
neonatal care - the administration of surfactant - as surfactant appeared a reasonable marker
for moderately preterm infants who require intubation. While this assumption seems
reasonable, it may not account for some intermediate neonatal-care programs which provide
care to infants who require central lines or pressor support without the need for mechanical
ventilation. We may have also missed a portion of infants who required intubation without
the need for surfactant, such as in the case of perinatal depression or respiratory distress
secondary to pneumonia. Furthermore, the cohort only included those infants who were
discharged home alive from the study hospital. Their severity of illness likely would have
qualified them as Level III infants. Although this is a potential source of bias, it is unlikely
to be significant given the low mortality of this gestational age group as compared to their
VLBW counterparts12, 14.
It must also be acknowledged that significant practice variation exists among NICUs 36, 37
and that this may alter the patient outcomes, such as intubation and receipt of surfactant.
Specifically, the case report forms did not collect information on whether surfactant was
given as a prophylactic or rescue strategy. In order to account for some of such variation, we
adjusted for both the state of birth (MA vs. CA) and the level of care (II vs. III) received by
the neonate, but neither factor was a statistically significant predictor of surfactant
administration in our multivariable logistic regression model. Since variation of perinatal
care, including the types of services offered at the designated levels of neonatal care, will
vary by regions and states beyond the units represented in this analysis 38, the application of
a clinical prediction rule such as the MATS will need to be considered in the context of each
individual area to help provide the most optimal outcomes. One approach that might be
undertaken by a region is to determine if it is best for them to optimize the sensitivity or
specificity of MATS. The optimal cut-off thresholds would have to be evaluated in the
context of optimal resource availability and utilization, including that of maternal-fetal and
neonatal transport.
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diabetes, hypertension, etc.) as candidate independent risk factors for neonatal morbidities,
especially in late-preterm infants 39. With only four factors used to predict the outcome, the
MATS is both parsimonious and has strong face validity, but its predictive validity might be
strengthened if other intrapartum and antepartum risk factors were available for analysis. We
also did not have the power to split the cohort to derive the MATS on one half and validate
it on the other, and therefore addressed this limitation using nonparametric bootstrapping
(Table 3). This issue will be addressed further by validation of MATS on an external cohort.
Finally, we must address the issue of generalizability of our cohort, which was a relatively
advantaged group, most of whom had received prenatal care, were highly educated and with
adequate family income. Given the evidence that preterm birth disproportionately affects
people of lower socioeconomic status, it will be important to validate this rule in other
populations prior to clinical use. Similarly, we did not attempt to validate the score on late-
preterm infants of gestational ages 35-0/7 to 36-6/7 weeks, who are also known to be at
increased risk for morbidities requiring tertiary level neonatal care are 39. Plans for such
extension to more diverse maternal and neonatal populations are underway.
In summary, the MATS provides reasonable discriminatory power to identify which infants
may require tertiary level care prior to delivery and thus prompt a maternal-fetal transport.
We hope that the provision of a best-care setting for at-risk infants would improve infant
outcomes at the population level and optimize resource utilization in regions where there are
barriers to neonatal transport.
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Receiver Operating Characteristic Curve
ROC curve for the MATS for the entire MPIP cohort. The area under the curve is 0.77 [0.73,
0.80]. The optimal cut off value for MATS depends on the perinatal regionalization network
that exists for a particular region and the associated trade-off from optimizing sensitivity
versus specificity.
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